Elyse Dickerson is CEO and Co-Founder of Eosera, Inc., a majority woman-owned biotech company committed to developing products that address underserved medical needs.
The co-founders of the Fort Worth based company are CEO Elyse Dickerson, and Joe Griffin Chief Scientific Officer, and while Griffin says his skills are on the scientific side, Dickerson’s skills are in commercialization and marketing.
TMAC works with companies of all sizes to help them achieve success, streamlining processes, improving products and developing people, as well as implementing emerging technologies.
Determined to find fulfillment in the job she does, Dickerson left the pharmaceutical company and started out on her own. After leaving her previous occupation, Dickerson started Eosera with the purpose to heal people.
CEO and Co-Founder of Eosera, Elyse Dickerson, started her own business because she wanted to use business as a force for good in the world. The FortWorth-based company is majority woman-owned biotechnology company that is committed to developing products that address underserved medical needs.
Amazon (AMZN) is reportedly looking for a new venture- in the pharmaceutical market. Earlier this year, the company began to sell medical supplies in the United States, including Eosera’s Earwax MD.
CEO and Co-Founder of Eosera, Inc., Elyse Dickerson, provides insight into how the two-year old company raised $1.2 million in just 3 months, with these 10 tips.
Eosera last week introduced a new earwax impaction solution, called Earwax MD, to hearing aid centers and audiologists to help improve hearing aid performance.
AudiologyNOW! attendees will be able to find EOSERA at Booth #213. Participants who use the hashtag #EarwaxMDAAA on social media will be entered in a drawing to win an Apple Watch.
Fort Worth-based Eosera is a biotech company that develops medical products for sale online and, eventually in stores. The company was founded by Elyse Dickerson and Joe Griffin, both veterans of the medical product industry.
A recent article in the Chain Drug Review introduces Earwax MD and describes its new approach for cerumen removal. Earwax MD is scheduled to launch in April 2017.
“In short, everyone needed a modern solution to combat earwax impaction. Eosera has developed it,” says Joe Griffin, co-founder & CSO.
Elyse Dickerson, co-founder of Fort Worth-based Eosera, Inc., a biotechnology company gearing up to launch Earwax MD, a topical drug that helps dissolve earwax, has won the Mary Kay Pink Tank Business Pitch Competition.
EOSERA, Inc., a Dallas-based biotechnology innovator founded by two veterans of the pharmaceutical industry, today announced the introduction of Earwax MD—the ideal solution for those who dread the time, worry, and expense of a doctor’s visit to clear their ears of burdensome earwax impaction.
Cerumen, otherwise known as earwax, can cause stuffiness, pain and hearing loss. Too much earwax sends some 12 million Americans to the doctor’s office each year.
A recent article in the Fort Worth, Inc. Magazine, Ear It Out, highlights the evolution of Eosera, and the development of its first product, an earwax removal aid.